NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, Par Value $0.01 per share
Shares outstanding
162,190,120
Number of holders
399
Total 13F shares, excl. options
33,397,602
Shares change
-3,998,999
Total reported value, excl. options
$4,783,479,130
Value change
-$707,719,453
Put/Call ratio
197%
Number of buys
174
Number of sells
-220
Price
$143.07

Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q4 2021

532 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q4 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 399 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 33,397,602 shares of 162,190,120 outstanding shares and own 20.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,897,007 shares), BlackRock Inc. (4,395,161 shares), RA CAPITAL MANAGEMENT, L.P. (2,097,794 shares), STATE STREET CORP (1,899,220 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,264,172 shares), HSBC HOLDINGS PLC (1,010,246 shares), GEODE CAPITAL MANAGEMENT, LLC (983,170 shares), MORGAN STANLEY (956,492 shares), Capital World Investors (875,148 shares), and JANE STREET GROUP, LLC (649,790 shares).
This table shows the top 399 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.